Moore John R: insider trades.
Moore John R reported 6 non-derivative transactions on 2 SEC ownership filings in Q3 2026: 0 open-market purchases and 4 sales ($220K), across 1 company.
- Transactions
- 6
- Purchases (P)
- 0
- Sales (S)
- 4
- Companies
- 1
- Name as filed
- MOORE JOHN R
Companies
| Company | Relationship | Transactions |
|---|---|---|
| Edgewise Therapeutics, Inc. (EWTX) | Officer · General Counsel | 6 |
Transactions
| Date | Company | Code | Shares | Price | Owned after | Filing |
|---|---|---|---|---|---|---|
| 2026-08-12 | Edgewise Therapeutics, Inc. | S | 2,439 | $43.81 | 20,274 | Form 4 |
| 2026-08-12 | Edgewise Therapeutics, Inc. | M | 6,718 | $0 | 22,713 | Form 4 |
| 2026-08-12 | Edgewise Therapeutics, Inc. | S | 59 | $44.41 | 20,215 | Form 4 |
| 2026-08-12 | Edgewise Therapeutics, Inc. | S | 99 | $44.5 | 20,116 | Form 4 |
| 2026-08-12 | Edgewise Therapeutics, Inc. | S | 2,419 | $43.8 | 17,697 | Form 4 |
| 2026-08-12 | Edgewise Therapeutics, Inc. | M | 5,781 | $0 | 15,995 | Form 4 |
Questions
What stock did Moore John R buy or sell?
Moore John R reported 6 non-derivative transactions on 2 SEC ownership filings in Q3 2026: 0 open-market purchases and 4 sales ($220K), across 1 company.
Is Moore John R the same person as other filers with this name?
This page covers SEC CIK 1191702 only. The SEC assigns each reporting owner a CIK, and people with the same name have different CIKs.
Source: SEC Insider Transactions Data Sets, Q3 2026. Reported as filed; we do not assess intent, performance or compliance. All filings for this CIK on SEC.gov.
Plain-text version for agents and LLMs: /insiders/moore-john-r-1191702.md
Independent. Not affiliated with, endorsed by, or sponsored by the U.S. Securities and Exchange Commission. Data is reproduced from public SEC filings and datasets. Not investment advice.